Influence of psychobiological predictors on the outcome of patients after allogeneic hematopoietic stem cell transplantation

INTRODUCTION: Allogeneic hematopoietic stem cell transplantation is a standard treatment for hematologic diseases. While biological predictors of transplant success are well established, psychobiological factors such as depression and physical activity remain underexplored. This study investigates their influence on clinical outcomes and quality of life after allogeneic hematopoietic stem cell transplantation. METHODS: In this prospective study, 42 patients undergoing transplantation (December 2020- December 2021) were assessed at four time points (T0-T3). Depression was assessed using the Patient Health Questionnaire-9, physical activity using the International Physical Activity Questionnaire, and quality of life using the Functional Assessment of Cancer Therapy-Leukemia and its Trial Outcome Index subscore. Bivariate correlations (p-value <0.05) were used to examine associations with clinical endpoints (leukocyte engraftment, GVHD, adverse events ≥ Grade III, relapse, mortality, and quality of life at six months). RESULTS: Higher depression at T0 (Mean: 6.53; SD: 4.98) predicted lower global quality of life at T3 (r = -0.46; p = 0.04), but not clinical outcomes. Physical activity at T0 (Mean: 4290.3; SD: 4242.7) showed no significant associations. Older age (Mean: 57.7; SD: 10.2) was linked to a better Trial Outcome Index (r = 0.5; p = 0.02), higher global quality of life (r = 0.45; p = 0.04), and lower depression (r = -0.56; p = 0.005) at T3. Complications had no effect on quality of life or depression. CONCLUSION: Depression before allogeneic hematopoietic stem cell transplantation may predict poorer quality of life afterward. Older age was associated with better outcomes, suggesting rigid age limits for allogeneic hematopoietic stem cell transplantation should be re-evaluated.

Authors

Institutions

Publication Details

Journal
Hematology Transfusion and Cell Therapy
Published
2026-11-12
DOI
https://doi.org/10.1016/j.htct.2026.108570
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Influence of psychobiological predictors on the outcome of patients after allogeneic hematopoietic stem cell transplantation

Corinna Trenker, Stefan Salzmann, Elisabeth Mack, Andreas Neubauer et al.
Hematology Transfusion and Cell Therapy
Hematopoietic Stem Cell Transplantation
article

Influence of psychobiological predictors on the outcome of patients after allogeneic hematopoietic stem cell transplantation

Corinna Trenker, Stefan Salzmann, Elisabeth Mack, Andreas Neubauer, Pia von Blanckenburg, Kristina Sohlbach, Ellen Wollmer, Jonas Schäfer, Marius Dohse, Philipp Lishewski, Lucas Beilharz, Winfried Rief
article en

Abstract

INTRODUCTION: Allogeneic hematopoietic stem cell transplantation is a standard treatment for hematologic diseases. While biological predictors of transplant success are well established, psychobiological factors such as depression and physical activity remain underexplored. This study investigates their influence on clinical outcomes and quality of life after allogeneic hematopoietic stem cell transplantation. METHODS: In this prospective study, 42 patients undergoing transplantation (December 2020- December 2021) were assessed at four time points (T0-T3). Depression was assessed using the Patient Health Questionnaire-9, physical activity using the International Physical Activity Questionnaire, and quality of life using the Functional Assessment of Cancer Therapy-Leukemia and its Trial Outcome Index subscore. Bivariate correlations (p-value <0.05) were used to examine associations with clinical endpoints (leukocyte engraftment, GVHD, adverse events ≥ Grade III, relapse, mortality, and quality of life at six months). RESULTS: Higher depression at T0 (Mean: 6.53; SD: 4.98) predicted lower global quality of life at T3 (r = -0.46; p = 0.04), but not clinical outcomes. Physical activity at T0 (Mean: 4290.3; SD: 4242.7) showed no significant associations. Older age (Mean: 57.7; SD: 10.2) was linked to a better Trial Outcome Index (r = 0.5; p = 0.02), higher global quality of life (r = 0.45; p = 0.04), and lower depression (r = -0.56; p = 0.005) at T3. Complications had no effect on quality of life or depression. CONCLUSION: Depression before allogeneic hematopoietic stem cell transplantation may predict poorer quality of life afterward. Older age was associated with better outcomes, suggesting rigid age limits for allogeneic hematopoietic stem cell transplantation should be re-evaluated.

Hematology Transfusion and Cell TherapyVol. 49(1)
Philipps University of Marburg (DE), University of Erfurt (DE), Universitätsklinikum Gießen und Marburg (DE), Vinzenz Pallotti University (DE), HMU Health and Medical University Erfurt (DE)
Deutsche Forschungsgemeinschaft
Good health and well-being
Hematopoietic Stem Cell Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon